RBC Capital reiterated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $9.00 from $13.00 previously

Royal Bank of Canada initiated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $13.00

RBC Capital initiated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $13.00

Royal Bank of Canada initiated coverage of Viemed Healthcare with a rating of Outperform

SC 13D/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

SC 13G - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

SC 13G - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

SC 13D/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

SC 13G - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

LAFAYETTE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and nine months ended September 30, 2024. Operational highlights (all dollar amounts are USD; comparisons are to the period ended September 30, 2023 unless otherwise noted): Net revenues increased 17.4% for the quarter ended September 30, 2024 to $58.0 million, setting another Company record, and increased 5.5% sequentially over the second quarter ended June 30, 2024. Excluding acquired revenue of $1.1 million

LAFAYETTE, La., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its third quarter 2024 earnings conference call on Thursday, November 7, 2024, at 12:00 p.m. EST. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=qSIpA5NC Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.

LAFAYETTE, La., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and six months ended June 30, 2024. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended June 30, 2024 reached a new Company record of $55.0 million, representing an increase of $11.7 million, or 27%, over net revenues reported for the comparable quarter ended June 30, 2023. This represents 9% sequential growth in revenue over the first quarter ended March 31, 2024. Ne

LAFAYETTE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Thursday, August 8, 2024 at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 888-437-3179 (US Toll-Free)+1 862-298-0702 (International) Financial professionals are invited to call in to register in advance to ask questions. To pre-register as a qualified caller, please e-mail [email protected] by 12:00 p.m. ET Wednesday, August 7, 2024. Live Audio Webcast: https://event.choruscall.co

LAFAYETTE, La., May 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2024. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2024 were $50.6 million, representing an increase of $11.0 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2023. Net income for the quarter ended March 31, 2024 totaled $1.6 million. Adjusted EBITDA for the quarter ended March 31, 2024 totaled $10

LAFAYETTE, La., April 23, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Tuesday, May 7, 2024 at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free)+1 201-689-8451 (International) Financial professionals are invited to call in to register in advance to ask questions. To pre-register as a qualified caller, please e-mail [email protected] by 12:00 p.m. ET Monday, May 6, 2024. Live Audio Webcast: https://event.choruscall.com/mediafr

LAFAYETTE, La., April 02, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced the finalization of its strategic partnership with East Alabama Health ("EAH"), providing Viemed with the controlling interest of East Alabama HomeMed, LLC ("HomeMed"). HomeMed provides home medical equipment services to patients within the EAH network as well as those in the surrounding areas of Eastern Alabama. "We are thrilled to join forces with the exceptional team at East Alabama Health to deliver best-in-class home medical services to their patients and expand Home

LAFAYETTE, La., March 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2023. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended December 31, 2023 reached a new Company record of $50.7 million representing an increase of $13.2 million, or 35%, over net revenues reported for the comparable quarter ended December 31, 2022. Total net revenues for the year ended December 31, 2023 were a record-breaking $183.0 mil

LAFAYETTE, La., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Year End Conference Call on Thursday, March 7, 2024 at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free)+1-201-689-8451 (International) Financial professionals are invited to call in to register in advance to ask questions. To pre-register as a qualified caller, please e-mail [email protected] by 12:00 p.m. ET Wednesday, March 6, 2024. Live Audio Webcast: https://event.choruscall.com/m

LAFAYETTE, La., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD, TSX:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced that it has applied and received approval from the Toronto Stock Exchange ("TSX") for the voluntary delisting of its common shares (each a "Common Share") from the TSX. The delisting from TSX will not affect the Company's listing on the NASDAQ Capital Market ("NASDAQ"). "The Company is taking strategic action to enhance market efficiency and optimize our administrative processes by consolidating trading volumes on NASDAQ, as the majority of both outstanding shares

LAFAYETTE, La., April 02, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced the finalization of its strategic partnership with East Alabama Health ("EAH"), providing Viemed with the controlling interest of East Alabama HomeMed, LLC ("HomeMed"). HomeMed provides home medical equipment services to patients within the EAH network as well as those in the surrounding areas of Eastern Alabama. "We are thrilled to join forces with the exceptional team at East Alabama Health to deliver best-in-class home medical services to their patients and expand Home

LAFAYETTE, La., June 13, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD, TSX:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced the voting results from its annual general meeting of shareholders held on June 13, 2023 (the "Meeting") in Lafayette, Louisiana. The total number of shares represented in person or by proxy at the Meeting was 27,309,147, representing 71.33% of the total issued and outstanding shares in the capital of the Company. Election of Directors The eight candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's m

LAFAYETTE, La., June 09, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD, TSX:VMD), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, today announced the voting results from its annual general meeting of shareholders held on June 9, 2022 (the "Meeting") in Lafayette, Louisiana. The total number of shares represented in person or by proxy at the Meeting was 25,092,560, representing 63.86% of the total issued and outstanding shares in the capital of the Company. Election of Directors The eight candidates nominated for election to the Company's Board of D

LAFAYETTE, La., June 10, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD.TO and NASDAQ:VMD), a home medical equipment supplier and the nation’s largest independent provider of ventilation that provides post-acute respiratory care services, today announced the voting results from its annual and special meeting of shareholders held on June 10, 2021 (the “Meeting”) in Lafayette, Louisiana. The total number of shares represented in person or by proxy at the Meeting was 25,380,544, representing 64.13% of the total issued and outstanding shares in the capital of the Company. Election of Directors The eight candidates nominated for election to the Company’

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by 42.86 percent. This is unchanged from the same period last year. The company reported quarterly sales of $50.593 million which beat the analyst consensus estimate of $50.000 million by 1.19 percent. This is a 27.90 percent increase over sales of $39.556 million the same period last year.

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced the finalization of its strategic partnership with East Alabama Health ("EAH"), providing Viemed with the controlling interest of East Alabama HomeMed, LLC ("HomeMed"). HomeMed provides home medical equipment services to patients within the EAH network as well as those in the surrounding areas of Eastern Alabama. "We are thrilled to join forces with the exceptional team at East Alabama Health to deliver best-in-class home medical services to their patients and expand HomeMed's business through the strategic partnership," sai

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.09 per share which missed the analyst consensus estimate of $0.10 by 10 percent. This is a 50 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $50.74 million which beat the analyst consensus estimate of $50.00 million by 1.48 percent. This is a 35.28 percent increase over sales of $37.51 million the same period last year.

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. • Foot Locker (NYSE:FL) is likely to report quarterly earnings at $0.32 per share on revenue of $2.28 billion. • JD.com (NASDAQ:JD) is likely to report quarterly earnings at $0.63 per share on revenue of $42.16 billion. • Super Group (SGHC) (NYSE:SGHC) is expected to report quarterly earnings at $0.01 per share on revenue of $326.63 million. • Sotherly Hotels (NASDAQ:SOHO) is projected to report earnings for its fourth quarter. • Thor Industries (NYSE:THO) is estimated to report quarterly earnings at $0.67 per share on revenue of $2.27 billion

Viemed Healthcare (NASDAQ:VMD) is set to give its latest quarterly earnings report on Wednesday, 2024-03-06. Here's what investors need to know before the announcement. Analysts estimate that Viemed Healthcare will report an earnings per share (EPS) of $0.10. Viemed Healthcare bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast). Historical Earnings Performance Last quarter the company missed EPS by $0.01, which was followed by a 12.0

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD, TSX:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced that it has applied and received approval from the Toronto Stock Exchange ("TSX") for the voluntary delisting of its common shares (each a "Common Share") from the TSX. The delisting from TSX will not affect the Company's listing on the NASDAQ Capital Market ("NASDAQ"). "The Company is taking strategic action to enhance market efficiency and optimize our administrative processes by consolidating trading volumes on NASDAQ, as the majority of both outstanding shares and trading volume is currently concentrated in the

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.08 by 12.5 percent. This is a 133.33 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $49.40 million which missed the analyst consensus estimate of $49.50 million by 0.20 percent. This is a 38.15 percent increase over sales of $35.76 million the same period last year.

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. • Ballys (NYSE:BALY) is estimated to report quarterly loss at $0.08 per share on revenue of $638.03 million. • Wingstop (NASDAQ:WING) is projected to report quarterly earnings at $0.51 per share on revenue of $108.72 million. • Seagen (NASDAQ:SGEN) is projected to report quarterly earnings at $0.80 per share on revenue of $634.14 million. • TG Therapeutics (NASDAQ:TGTX) is expected to report quarterly earnings at $0.12 per share on revenue of $46.56 million. • Mastech Digital (AMEX:MHH) is likely to report quarterly earnings at $0.13 per share on

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on revenue of $18.11 billion. • ICL Group (NYSE:ICL) is expected to report quarterly earnings at $0.12 per share on revenue of $2.02 billion. • CAE (NYSE:CAE) is expected to report quarterly earnings at $0.16 per share on revenue of $762.48 million. • Sprott (NYSE:SII) is projected to report quarterly earnings at $0.46 per share on revenue of $50.42 million. • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.05 per share on revenue of $242.70 million. • Nomad Foods (NYSE:NOMD) is likely to report quarterly earnings at $0.40 per share on re